The global pneumonia vaccines market was valued at $7,083 million in 2017 and is expected to reach $10,215 million by 2025, growing at a CAGR of 5% from 2018 to 2025.
Report Code : A02397 | Pages : 171 | Category : Life Sciences
The global in vitro diagnostics market was valued at $92.5 billion in 2022, and is projected to reach $138.4 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032.
Report Code : A00245 | Pages : 391 | Category : Life Sciences
The global molecular diagnostics market was valued at $9.2 billion in 2020, and is projected to reach $23.9 billion by 2030, growing at a CAGR of 9.86% from 2021 to 2030.
Report Code : A01840 | Pages : 256 | Category : Life Sciences
The global global sepsis diagnostic market was valued at $569.49 million in 2020, and is projected to reach $1.2 billion by 2030, growing at a CAGR of 7.8% from 2021 to 2030.
Report Code : A03908 | Pages : 205 | Category : Life Sciences
Antibiotic is an antimicrobial substance, which combats bacterial infections and occasionally protozoan infections. In addition, they are used to cure several diseases such as strep throat, urinary tract ...
Report Code : A04710 | Pages : 282 | Category : Life Sciences
The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026.
Report Code : A03624 | Pages : 178 | Category : Life Sciences
The global api intermediate market was valued at $139.4 billion in 2022, and is projected to reach $285 billion by 2032, growing at a CAGR of 7.4% from 2023 to 2032.
Report Code : A02308 | Pages : 390 | Category : Life Sciences
The global BCG vaccine market was valued at $46,637.5 thousands in 2020, and is projected to reach $74,269.55 thousands by 2030, registering a CAGR of 4.8% from 2021 to 2030.
Report Code : A04070 | Pages : 165 | Category : Life Sciences
The global anti-rheumatics market accounted for $57,229 million in 2018 and is expected to reach $71,934 million by 2026, registering a CAGR of 2.9% from 2019 to 2026.
Report Code : A05924 | Pages : 202 | Category : Life Sciences
The global hospital-acquired infection diagnostics market was valued at $3.4 billion in 2020, and is projected to reach $7.0 billion by 2030, growing at a CAGR of 7.6% from 2021 to 2030.
Report Code : A04098 | Pages : 210 | Category : Life Sciences
